Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.915 SEK
−83.13 M SEK
94.63 M SEK
80.12 M
About IRLAB Therapeutics AB Class A
Sector
Industry
CEO
Kristina Torfgård
Website
Headquarters
Gothenburg
Founded
2013
ISIN
SE0012675361
FIGI
BBG00G3F2C80
IRLAB Therapeutics AB engages in the provision of novel treatments for disorders of the brain that focuses on illness in the central nervous system. The fim develops drugs for Parkinson's disease. It also offers IRL752 that targets dementia in Parkinson's disease. The company was founded in 2013 and is headquartered in Gothenburg, Sweden.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IRLAB_A is 2.720 SEK — it has decreased by −3.45% in the past 24 hours. Watch IRLAB Therapeutics AB Class A stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange IRLAB Therapeutics AB Class A stocks are traded under the ticker IRLAB_A.
IRLAB_A stock has fallen by −10.69% compared to the previous week, the month change is a −12.36% fall, over the last year IRLAB Therapeutics AB Class A has showed a −80.13% decrease.
We've gathered analysts' opinions on IRLAB Therapeutics AB Class A future price: according to them, IRLAB_A price has a max estimate of 17.00 SEK and a min estimate of 17.00 SEK. Watch IRLAB_A chart and read a more detailed IRLAB Therapeutics AB Class A stock forecast: see what analysts think of IRLAB Therapeutics AB Class A and suggest that you do with its stocks.
IRLAB_A reached its all-time high on Jul 10, 2019 with the price of 102.050 SEK, and its all-time low was 2.990 SEK and was reached on Sep 1, 2025. View more price dynamics on IRLAB_A chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
IRLAB_A stock is 7.01% volatile and has beta coefficient of 0.21. Track IRLAB Therapeutics AB Class A stock price on the chart and check out the list of the most volatile stocks — is IRLAB Therapeutics AB Class A there?
Today IRLAB Therapeutics AB Class A has the market capitalization of 246.32 M, it has decreased by −0.33% over the last week.
Yes, you can track IRLAB Therapeutics AB Class A financials in yearly and quarterly reports right on TradingView.
IRLAB Therapeutics AB Class A is going to release the next earnings report on Oct 29, 2025. Keep track of upcoming events with our Earnings Calendar.
IRLAB_A net income for the last quarter is −32.31 M SEK, while the quarter before that showed −33.97 M SEK of net income which accounts for 4.87% change. Track more IRLAB Therapeutics AB Class A financial stats to get the full picture.
No, IRLAB_A doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 10, 2025, the company has 33 employees. See our rating of the largest employees — is IRLAB Therapeutics AB Class A on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IRLAB Therapeutics AB Class A EBITDA is −94.48 M SEK, and current EBITDA margin is −92.83%. See more stats in IRLAB Therapeutics AB Class A financial statements.
Like other stocks, IRLAB_A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IRLAB Therapeutics AB Class A stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IRLAB Therapeutics AB Class A technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IRLAB Therapeutics AB Class A stock shows the sell signal. See more of IRLAB Therapeutics AB Class A technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.